First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response
Friday, 22 May 2020 () A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.
A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe.
It induced a rapid immune response in its first human trial, Reuters reports.
This vaccine did not cause any serious adverse effects, though side effects such as fever were noted.
Blood samples from the 108 vaccinated...
A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on... Reuters India Also reported by •Zee News